id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-033356-ppn71yd0	Abbott, Frederick M	Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic	2020-09-28		.txt	text/plain	10042	481	41	The authors finally address the problem created by the decision of various high-income countries to 'opt out' as eligible importing countries under the World Trade Organization TRIPS Agreement Article 31bis amendment that addresses the predominant export of pharmaceutical products under compulsory licenses. 18 At the time of writing, a number of pharmaceutical companies that are receiving substantial government subsidies to develop vaccines and treatments to address COVID-19 have declared that they intend to provide them on a 'not-for-profit' basis, although nothing in their grant arrangements appears to require specific pricing commitments, 19 and there is limited public transparency on this account. 70 For present purposes, we emphasize that a pooled procurement strategy along these lines would also greatly strengthen the inherent power of governments in developing countries to threaten and, when needed, to issue compulsory licenses for patented pharmaceuticals under Articles 31 and 31bis of the TRIPS Agreement.	./cache/cord-033356-ppn71yd0.txt	./txt/cord-033356-ppn71yd0.txt